Insider Trading Claims In Sanofi-Bioverativ Suit Move Forward
Former Bioverativ Inc. board member Alexander J. Denner and the activist hedge fund he controlled must face insider trading claims in a Delaware Chancery Court lawsuit alleging an unfair deal process...To view the full article, register now.
Already a subscriber? Click here to view full article